D
Autolus Therapeutics plc
AUTL
$1.57
$0.1611.35%
D
Sell
10/3/2023Upgraded
Autolus Therapeutics plc (AUTL) was upgraded to D- from E+ on 10/3/2023 due to an increase in the volatility index and valuation index.
Autolus Therapeutics plc (AUTL) was upgraded to D- from E+ on 10/3/2023 due to an increase in the volatility index and valuation index.
E
Sell
9/18/2023Downgrade
Autolus Therapeutics plc (AUTL) was downgraded to E+ from D- on 9/18/2023 due to a decline in the volatility index and total return index.
Autolus Therapeutics plc (AUTL) was downgraded to E+ from D- on 9/18/2023 due to a decline in the volatility index and total return index.
D
Sell
8/28/2023Upgraded
Autolus Therapeutics plc (AUTL) was upgraded to D- from E+ on 8/28/2023 due to an increase in the volatility index and total return index.
Autolus Therapeutics plc (AUTL) was upgraded to D- from E+ on 8/28/2023 due to an increase in the volatility index and total return index.
E
Sell
8/11/2023Downgrade
Autolus Therapeutics plc (AUTL) was downgraded to E+ from D- on 8/11/2023 due to a noticeable decline in the growth index, volatility index and solvency index. Debt to equity increased from 0.02 to 0.03, EBIT declined 21.68% from -$39.34M to -$47.86M, and earnings per share declined from -$0.229 to -$0.262.
Autolus Therapeutics plc (AUTL) was downgraded to E+ from D- on 8/11/2023 due to a noticeable decline in the growth index, volatility index and solvency index. Debt to equity increased from 0.02 to 0.03, EBIT declined 21.68% from -$39.34M to -$47.86M, and earnings per share declined from -$0.229 to -$0.262.
D
Sell
7/24/2023Upgraded
Autolus Therapeutics plc (AUTL) was upgraded to D- from E+ on 7/24/2023 due to an increase in the volatility index and total return index.
Autolus Therapeutics plc (AUTL) was upgraded to D- from E+ on 7/24/2023 due to an increase in the volatility index and total return index.
E
Sell
7/7/2023Downgrade
Autolus Therapeutics plc (AUTL) was downgraded to E+ from D- on 7/7/2023 due to a decline in the volatility index.
Autolus Therapeutics plc (AUTL) was downgraded to E+ from D- on 7/7/2023 due to a decline in the volatility index.
D
Sell
6/15/2023Upgraded
Autolus Therapeutics Plc (AUTL) was upgraded to D- from E+ on 6/15/2023 due to an increase in the total return index and volatility index.
Autolus Therapeutics Plc (AUTL) was upgraded to D- from E+ on 6/15/2023 due to an increase in the total return index and volatility index.
E
Sell
3/14/2023Downgrade
Autolus Therapeutics plc (AUTL) was downgraded to E+ from D on 03/14/2023.
Autolus Therapeutics plc (AUTL) was downgraded to E+ from D on 03/14/2023.
D
Sell
3/8/2023Upgraded
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 3/8/2023 due to a major increase in the growth index, solvency index and volatility index. The quick ratio increased from 5.26 to 8.87, total revenue increased 61.46% from $2.37M to $3.83M, and operating cash flow increased 54.34% from -$31.9M to -$14.57M.
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 3/8/2023 due to a major increase in the growth index, solvency index and volatility index. The quick ratio increased from 5.26 to 8.87, total revenue increased 61.46% from $2.37M to $3.83M, and operating cash flow increased 54.34% from -$31.9M to -$14.57M.
D
Sell
2/27/2023Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 2/27/2023 due to a decline in the volatility index and total return index.
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 2/27/2023 due to a decline in the volatility index and total return index.
D
Sell
2/6/2023Upgraded
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 2/6/2023 due to an increase in the volatility index.
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 2/6/2023 due to an increase in the volatility index.
D
Sell
1/20/2023Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 1/20/2023 due to a decline in the volatility index and total return index.
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 1/20/2023 due to a decline in the volatility index and total return index.
D
Sell
1/4/2023Upgraded
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 1/4/2023 due to an increase in the volatility index.
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 1/4/2023 due to an increase in the volatility index.
D
Sell
12/20/2022Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 12/20/2022 due to a decline in the solvency index and volatility index. The quick ratio declined from 7.13 to 5.26.
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 12/20/2022 due to a decline in the solvency index and volatility index. The quick ratio declined from 7.13 to 5.26.
D
Sell
8/29/2022Upgraded
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 8/29/2022 due to an increase in the total return index and volatility index.
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 8/29/2022 due to an increase in the total return index and volatility index.
D
Sell
8/8/2022Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 8/8/2022 due to a major decline in the growth index, solvency index and total return index. The quick ratio declined from 10.42 to 7.13, earnings per share declined from -$0.4077 to -$0.4625, and EBIT declined 11.24% from -$41.78M to -$46.48M.
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 8/8/2022 due to a major decline in the growth index, solvency index and total return index. The quick ratio declined from 10.42 to 7.13, earnings per share declined from -$0.4077 to -$0.4625, and EBIT declined 11.24% from -$41.78M to -$46.48M.
D
Sell
5/16/2022Upgraded
Autolus Therapeutics plc (AUTL) was upgraded to D from E+ on 05/16/2022.
Autolus Therapeutics plc (AUTL) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to E+ from D on 5/13/2022 due to a decline in the solvency index and total return index. Debt to equity increased from 0.01 to 0.02, and the quick ratio declined from 11.79 to 10.42.
Autolus Therapeutics Plc (AUTL) was downgraded to E+ from D on 5/13/2022 due to a decline in the solvency index and total return index. Debt to equity increased from 0.01 to 0.02, and the quick ratio declined from 11.79 to 10.42.
D
Sell
5/4/2022Upgraded
Autolus Therapeutics plc (AUTL) was upgraded to D from E+ on 05/04/2022.
Autolus Therapeutics plc (AUTL) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
Autolus Therapeutics Plc (AUTL) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
Autolus Therapeutics Plc (AUTL) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and valuation index.
Autolus Therapeutics Plc (AUTL) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and valuation index.
E
Sell
4/20/2022Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to E+ from D on 4/20/2022 due to a decline in the total return index, volatility index and solvency index.
Autolus Therapeutics Plc (AUTL) was downgraded to E+ from D on 4/20/2022 due to a decline in the total return index, volatility index and solvency index.
D
Sell
11/10/2021Upgraded
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 11/10/2021 due to an increase in the total return index.
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 11/10/2021 due to an increase in the total return index.
D
Sell
11/8/2021Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 11/8/2021 due to a decline in the solvency index.
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 11/8/2021 due to a decline in the solvency index.
D
Sell
5/7/2021Upgraded
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 5/7/2021 due to a noticeable increase in the growth index and solvency index. Debt to equity declined from 0.02 to 0.01, the quick ratio increased from 5.44 to 7.81, and earnings per share increased from -$0.8209 to -$0.5327.
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 5/7/2021 due to a noticeable increase in the growth index and solvency index. Debt to equity declined from 0.02 to 0.01, the quick ratio increased from 5.44 to 7.81, and earnings per share increased from -$0.8209 to -$0.5327.
D
Sell
3/22/2021Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 3/22/2021 due to a decline in the total return index and volatility index.
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 3/22/2021 due to a decline in the total return index and volatility index.
D
Sell
3/5/2021Upgraded
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 3/5/2021 due to an increase in the growth index and valuation index. Operating cash flow increased 29.01% from -$39.06M to -$27.73M.
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 3/5/2021 due to an increase in the growth index and valuation index. Operating cash flow increased 29.01% from -$39.06M to -$27.73M.
D
Sell
2/25/2021Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 2/25/2021 due to a decline in the total return index and volatility index.
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 2/25/2021 due to a decline in the total return index and volatility index.
D
Sell
8/27/2020Upgraded
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 8/27/2020 due to an increase in the volatility index, solvency index and total return index.
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 8/27/2020 due to an increase in the volatility index, solvency index and total return index.
D
Sell
8/12/2020Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 8/12/2020 due to a noticeable decline in the solvency index and growth index. Debt to equity increased from 0.01 to 0.02, the quick ratio declined from 10.54 to 8.94, and total revenue declined 13.31% from $338 to $293.
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 8/12/2020 due to a noticeable decline in the solvency index and growth index. Debt to equity increased from 0.01 to 0.02, the quick ratio declined from 10.54 to 8.94, and total revenue declined 13.31% from $338 to $293.
D
Sell
6/30/2020Upgraded
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 6/30/2020 due to an increase in the solvency index, volatility index and total return index. The quick ratio increased from 9.65 to 10.54.
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 6/30/2020 due to an increase in the solvency index, volatility index and total return index. The quick ratio increased from 9.65 to 10.54.
D
Sell
3/6/2020Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 3/6/2020 due to a decline in the efficiency index, solvency index and growth index. Net income declined 50.26% from -$27.25M to -$40.94M, earnings per share declined from -$0.6122 to -$0.9176, and operating cash flow declined 35.86% from -$24.49M to -$33.27M.
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 3/6/2020 due to a decline in the efficiency index, solvency index and growth index. Net income declined 50.26% from -$27.25M to -$40.94M, earnings per share declined from -$0.6122 to -$0.9176, and operating cash flow declined 35.86% from -$24.49M to -$33.27M.
D
Sell
12/18/2019Upgraded
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 12/18/2019 due to an increase in the total return index and volatility index.
Autolus Therapeutics Plc (AUTL) was upgraded to D from D- on 12/18/2019 due to an increase in the total return index and volatility index.
D
Sell
11/12/2019Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 11/12/2019 due to a major decline in the volatility index, total return index and efficiency index. Total capital declined 9% from $325.64M to $296.33M.
Autolus Therapeutics Plc (AUTL) was downgraded to D- from D on 11/12/2019 due to a major decline in the volatility index, total return index and efficiency index. Total capital declined 9% from $325.64M to $296.33M.
D
Sell
12/19/2018Downgrade
Autolus Therapeutics Plc (AUTL) was downgraded to D from D+ on 12/19/2018 due to a decline in the volatility index.
Autolus Therapeutics Plc (AUTL) was downgraded to D from D+ on 12/19/2018 due to a decline in the volatility index.
D
Sell
11/28/2018None
Autolus Therapeutics plc (AUTL) was downgraded to D+ from U on 11/28/2018.
Autolus Therapeutics plc (AUTL) was downgraded to D+ from U on 11/28/2018.
NASDAQ
04/02/2025 4:00PM Eastern
Quotes delayed
